Long-term outcomes and immune profiling in children with multisystem inflammatory syndrome (MIS-C)

Indira Jaxybayeva1, Riza Boranbayeva2, Minira Bulegenova3

  • 1Asfendiyarov Kazakh National Medical University. ind.88@mail.ru.

PubMed

Insights

Children with multisystem inflammatory syndrome (MIS-C) can experience long-term somatic disorders and immune changes. Most patients show subclinical heart issues within a year, indicating ongoing health impacts after MIS-C.

Area of Science:

  • Pediatric Cardiology
  • Immunology
  • Infectious Diseases

Background:

  • Follow-up data for multisystem inflammatory syndrome in children (MIS-C) is limited.
  • Understanding long-term consequences is crucial for pediatric patient care.

Purpose of the Study:

  • To investigate the long-term consequences in children who have undergone MIS-C.
  • To identify specific somatic disorders and immune system changes post-MIS-C.

Main Methods:

  • A retrospective study of 93 children with MIS-C, analyzing outcomes over periods up to 2+ years.
  • Prospective immunophenotyping and cytokine analysis in 31 children during acute and post-discharge phases.
  • Monitoring included outpatient events and cardiovascular system assessments.

Main Results:

  • Common outpatient findings included pneumonia, somatic disorder syndrome, visual impairment, and joint damage.
  • Cardiovascular changes observed included decreased heart dilatation and improved left ventricular function, but increased valve regurgitation and arrhythmias.
  • Immune profiling revealed T-lymphocyte and NK-cell reconstitution, with specific alterations in B-cells and other immune markers.

Conclusions:

  • Children with a history of MIS-C face diverse long-term somatic disorders and potential disease recurrence.
  • Subclinical myocardial involvement is prevalent within the first year post-MIS-C.
  • Altered immune cell expression, such as low CD95, may play a role in MIS-C pathogenesis.
Abstract